Aligning cancer quality metrics across the continuum of community-based and academic medicine using a prioritization tool. This is an ASCO Meeting Abstract from the 2012 Quality Care Symposium. This ...
An affordable new BRCA gene test has hit the market, but who should take it? — -- A new genetic testing kit that hits the market today is the most affordable, and arguably one of the simplest, ...
The model suggests that negative KRAS findings are believable when the maximum of APC and TP53 frequencies is at least 8% (corresponding posterior probability of false negative <5%). Validation ...
To ensure it complies with the CE marking, the DNA is first isolated from a specimen of formalin-fixed paraffin-embedded tissue using the QIAamp DNA FFPE Tissue Kit. The total amount of DNA in the ...
Previously, it was recommended for women who have a family history of breast, ovarian, tubal or peritoneal cancer to be assessed for harmful BRCA1 or BRCA2 mutations. That recommendation was last made ...
Duchenne (DMD) and Becker (BMD) muscular dystrophies are allelic neuromuscular disorders which are caused by defects of the dystrophin gene, one third of which arising from new mutations. This 2.5-Mb ...
A new report shows better than 80% concordance between liquid biopsy and tissue biopsy. Liquid biopsy and analysis of circulating tumor DNA (ctDNA) is a viable option for determining the presence of ...
PROVIDENCE, R.I. [Brown University] -- Tests that can distinguish whether HIV-positive people are infected with a drug-resistant strain or a non-resistant strain allow patients to get the most ...
In Brazil, the early detection of genetic alterations in lung cancer through liquid biopsies could be a valuable tool for expediting diagnoses and guiding patient treatment.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback